Edit ICD10 dx: Anticoagulant, adverse effect

unstructured part of page:

{{ICD10 transition status | OldDxArticle =Other OD | CurrentStatus = reconciled | InitialEditorAssigned = Not assigned }} == Additional Info == Excludes: * [[Hemorrhage, due to anticoagulant or thrombolytic drug]] * [[Thrombolytic drug, adverse effect]] * [[Aspirin or other salicylate or NSAID, adverse effect]] * Adverse effects of other anti-platelet agents (e.g. clopidogrel (Plavix), prasugrel (Effient), ticagrelor (Brilinta)) *To code anti-platelet drugs see [[Drug or biological substance/agent NOS, adverse effect]] Includes: * coumadin * heparin -- i.e. "regular" (unfractionated) heparin * the low molecular weight heparins (LMWH): Enoxaparin, Dalteparin, Tinzaparin, Bemiparin, Nadroparin, Reviparin, Parnaparin, Certoparin, * the new oral anticoagulants (NOACs): apixaban (Eliquis), betrixaban (BevyxXa), dabigatran (Pradaxa), edoxaban (Savaysa) and rivaroxaban (Xarelto), and others will probably be created also If present also code {{ListICD10Category | categoryName = Hemorrhage}} {{ICD10 Guideline adverse effect}} == Alternate ICD10s to consider coding instead or in addition == * [[Anticoagulant, overdose/toxicity]] {{ListICD10Category | categoryName = Adverse effect}} {{ListICD10Category | categoryName = Hemorrhage}} == Candidate [[Combined ICD10 codes]] == {{ListICD10Category | categoryName = Hemorrhage}} == Related CCI Codes == {{Data Integrity Check List}} == Related Articles == {{Related Articles}} {{ICD10 footer}} {{EndPlaceHolder}}

Save page Show preview Show changes Cancel